Australian snakebite myotoxicity (ASP-23)

References

• Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLOS Med. 2008;5(11):e218.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Brown SG, Page CB, et al. Snakebite in Australia: a practical approach to diagnosis and treatment. Med J Australia. 2013;199(11):763–768.
   PubMed Web of Science ®Google Scholar
• Johnston CI, Ryan NM, Page CB, et al. The Australian snakebite project, 2005–2015 (ASP-20). Med J Australia. 2017;207(3):119–125.
   PubMed Web of Science ®Google Scholar
• Gutiérrez JM, Ponce-Soto LA, Marangoni S, et al. Systemic and local myotoxicity induced by snake venom group II phospholipases A2: comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue. Toxicon. 2008;51(1):80–92.
   PubMed Web of Science ®Google Scholar
• Johnston CI, Brown SGA, O'Leary MA, ASP investigators, et al. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy – Australian Snakebite Project (ASP-19). Clinical Toxicology. 2013;51(5):417–424.
   Web of Science ®Google Scholar
• Reid HA. Diagnosis, prognosis, and treatment of sea-snake bite. Lancet. 1961;2(7199):399–402.
   PubMed Web of Science ®Google Scholar
• Lomonte B, Angulo Y, Calderón L. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon. 2003;42(8):885–901.
   PubMed Web of Science ®Google Scholar
• Sutherland SK, Campbell D, Stubbs A. A study of the major Australian snake venoms in the monkey (macaca fascicularis) II. Myolytic and haematological effects of venoms. Pathology. 1981;13(4):705–715.
   PubMed Web of Science ®Google Scholar
• Mebs D, Samejima Y. Purification, from Australian elapid venoms, and properties of phospholipases A which cause myoglobinuria in mice. Toxicon. 1980;18(4):443–454.
   PubMed Web of Science ®Google Scholar
• Harris J, Johnson MA. Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus. Clin Experiment Pharmacol Physiol. 1978;5(6):587–600.
   PubMed Web of Science ®Google Scholar
• Fohlman J, Eaker D. Isolation and characterization of a lethal myotoxic phospholipase A from the venom of the common sea snake Enhydrina schistosa causing myoglobinuria in mice. Toxicon. 1977;15(5):385–393.
   PubMed Web of Science ®Google Scholar
• Hodgson WC, Eriksson CO, Alewood PF, et al. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom. Clin Experiment Pharmacol Physiol. 2003;30(3):127–132.
   PubMed Web of Science ®Google Scholar
• Leonardi T, Howden M, Spence I. A lethal myotoxin isolated from the venom of the Australian king brown snake (Pseudechis australis). Toxicon. 1979;17(6):549–555.
   PubMed Web of Science ®Google Scholar
• Weinstein SA, Bell RC, Brown IIC, et al. Pathologic changes induced by phospholipase A2 isolated from the venom of Collett's snake, Pseudechis colletti: a light and electron microscopic study. Toxicon. 1992;30(2):171–185.
   PubMed Web of Science ®Google Scholar
• Harris J, Maltin C. Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus. Brit J Pharmacol. 1982;76(1):61–75.
   PubMed Web of Science ®Google Scholar
• Wickramaratna JC, Fry BG, Hodgson WC. Species-dependent variations in the in vitro myotoxicity of death adder (Acanthophis) venoms. Toxicol Sci. 2003;74(2):352–360.
   PubMed Web of Science ®Google Scholar
• Johnston CI, Ryan NM, O’Leary MA, et al. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy–Australian Snakebite Project (ASP-25. Clin Toxicol. 2017;55(2):115–122.
   PubMed Web of Science ®Google Scholar
• Churchman A, O'Leary MA, Buckley NA, et al. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Med J Australia. 2010;193(11–12):696–700.
   PubMed Web of Science ®Google Scholar
• Isbister GK, O'Leary MA, Elliott M, et al. Tiger snake (Notechis spp) envenoming: Australian snakebite project (ASP-13). Med J Australia. 2012;197(3):173–177.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Hooper M, Dowsett R, et al. Collett's snake (Pseudechis colletti) envenoming in snake handlers. QJM. 2006;99(2):109–115.
   PubMed Web of Science ®Google Scholar
• Gan M, O'Leary MA, Brown SGA, et al. Envenoming by the rough‐scaled snake (Tropidechis carinatus): a series of confirmed cases. Med J Australia. 2009;191(3):183–186.
   PubMed Web of Science ®Google Scholar
• Johnston CI, O'Leary MA, Brown SG, ASP Investigators, et al. Death adder envenoming causes neurotoxicity not reversed by antivenom-Australian Snakebite Project (ASP-16). Plos Negl Trop Dis. 2012;6(9):e1841.
   PubMed Web of Science ®Google Scholar
• Wallimann T, Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem. 1994;133-134(1):193–220.
   PubMed Web of Science ®Google Scholar
• Clarkson PM, Nosaka K, Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exercise. 1992;24(5):512–520.
   PubMed Web of Science ®Google Scholar
• Hart AJ, Hodgson WC, O'Leary M, et al. Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat. Clin Toxicol. 2014;52(6):604–610.
   Web of Science ®Google Scholar
• Kulawickrama S, O'Leary MA, Hodgson WC, et al. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum. Toxicon. 2010;55(8):1510–1518.
   PubMed Web of Science ®Google Scholar
• Ireland G, Brown SG, Buckley NA, Australian Snakebite Project Investigators, et al. Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming? Med J Australia. 2010;193(5):285–290.
   PubMed Web of Science ®Google Scholar
• Isbister GK. Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost. 2010;36(04):444–451.
   PubMed Web of Science ®Google Scholar
• Berling I, Brown SG, Miteff F, et al. Intracranial haemorrhages associated with venom induced consumption coagulopathy in Australian snakebites (ASP-21). Toxicon. 2015;102:8–13.
   PubMed Web of Science ®Google Scholar
• Weibrecht K, Dayno M, Darling C, et al. Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury. J Med Toxicol. 2010;6(3):294–300.
   PubMedGoogle Scholar
• Maduwage K, O'leary MA, Isbister GK. Diagnosis of snake envenomation using a simple phospholipase A2 assay. Sci Rep. 2014;4:4827.
   PubMed Web of Science ®Google Scholar
• Weinstein SA, Mirtschin PJ, White J. Risks and realities of single vial antivenom recommendations for envenoming by Australian elapid snakes. Med J Australia. 2019;211(11):492–493. e1.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Buckley NA. Risks and realities of single vial antivenom recommendations for envenoming by Australian elapid snakes. Med J Australia. 2020;213(1):45–45.e1.
   PubMed Web of Science ®Google Scholar